Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Böhringer"'
Autor:
Thomas Reinhard, Daniel Böhringer, Thabo Lapp, Viviane Grewing, Marianne Fritz, Daniel Zander, Philip Maier, Katrin Wacker
Publikováno v:
Ophthalmology. 128:1527-1533
Purpose The Eye Drops for Early Morning-Associated Swelling (EDEMAS) trial assessed the efficacy of hyperosmolar eye drops on corneal edema resolution. Design Double-masked, randomized controlled trial of hyperosmolar eye drops. Participants Particip
Autor:
Katrin Wacker, Thomas Reinhard, Philip Maier, Marianne Fritz, Daniel Böhringer, Thabo Lapp, Viviane Grewing
Publikováno v:
American Journal of Ophthalmology. 197:1-6
Purpose It is unclear which patients unexpectedly have a hyperopic refractive outcome after combined Descemet membrane endothelial keratoplasty and cataract surgery (triple DMEK). We assessed how corneal shape predicts hyperopia after triple DMEK. De
Autor:
Antoine Ferry, Felix Bock, Frank Wilhelm, Daniel Böhringer, Tobias Meyer-ter-Vehn, Björn Bachmann, Beatrice E. Frueh, Salman Al Mahmood, François Majo, Uwe Pleyer, Daniel Meller, Bernard Geudelin, Pavla Kadlecová, Gerd Geerling, Eric Viaud, Thomas Reinhard, Claus Cursiefen, Berthold Seitz, Michel Lévy, Sylvie Colin, Eric Thorin
Publikováno v:
Ophthalmology. 121(9):1683-1692
Objective Eye drops of aganirsen, an antisense oligonucleotide preventing insulin receptor substrate-1 expression, inhibited corneal neovascularization in a previous dose-finding phase II study. We aimed to confirm these results in a phase III study
Autor:
Erhard Godehardt, Olaf Cartsburg, Rainer Sundmacher, Daniel Böhringer, Erik De Clercq, Michael Roggendorf, Thomas Reinhard, Jost Hillenkamp, R. S. Ross
Publikováno v:
Ophthalmology. 109:845-850
Objective To evaluate the efficacy of cidofovir 1% eyedrops with and without cyclosporin A 1% eyedrops as a treatment of acute adenoviral keratoconjunctivitis (AKC). Design Randomized, controlled trial. Participants Thirty-four patients with acute ad
Publikováno v:
American Journal of Ophthalmology. 149:687-688